These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 16511930

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effectiveness, side-effects and period of remission after treatment with methotrexate in localized scleroderma and related sclerotic skin diseases: an inception cohort study.
    Kroft EB, Creemers MC, van den Hoogen FH, Boezeman JB, de Jong EM.
    Br J Dermatol; 2009 May; 160(5):1075-82. PubMed ID: 19210503
    [Abstract] [Full Text] [Related]

  • 7. Methotrexate treatment in juvenile localized scleroderma: a randomized, double-blind, placebo-controlled trial.
    Zulian F, Martini G, Vallongo C, Vittadello F, Falcini F, Patrizi A, Alessio M, La Torre F, Podda RA, Gerloni V, Cutrone M, Belloni-Fortina A, Paradisi M, Martino S, Perilongo G.
    Arthritis Rheum; 2011 Jul; 63(7):1998-2006. PubMed ID: 21305525
    [Abstract] [Full Text] [Related]

  • 8. Methotrexate and corticosteroids in the treatment of localized scleroderma: a standardized prospective longitudinal single-center study.
    Torok KS, Arkachaisri T.
    J Rheumatol; 2012 Feb; 39(2):286-94. PubMed ID: 22247357
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and safety of methotrexate in recalcitrant cutaneous lupus erythematosus: results of a retrospective study in 43 patients.
    Wenzel J, Brähler S, Bauer R, Bieber T, Tüting T.
    Br J Dermatol; 2005 Jul; 153(1):157-62. PubMed ID: 16029342
    [Abstract] [Full Text] [Related]

  • 10. Adjunctive methotrexate for treatment of giant cell arteritis: an individual patient data meta-analysis.
    Mahr AD, Jover JA, Spiera RF, Hernández-García C, Fernández-Gutiérrez B, Lavalley MP, Merkel PA.
    Arthritis Rheum; 2007 Aug; 56(8):2789-97. PubMed ID: 17665429
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Takayasu arteritis in children: preliminary experience with cyclophosphamide induction and corticosteroids followed by methotrexate.
    Ozen S, Duzova A, Bakkaloglu A, Bilginer Y, Cil BE, Demircin M, Davin JC, Bakkaloğlu M.
    J Pediatr; 2007 Jan; 150(1):72-6. PubMed ID: 17188618
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Clinical features and outcome of pediatric Wegener's granulomatosis.
    Akikusa JD, Schneider R, Harvey EA, Hebert D, Thorner PS, Laxer RM, Silverman ED.
    Arthritis Rheum; 2007 Jun 15; 57(5):837-44. PubMed ID: 17530684
    [Abstract] [Full Text] [Related]

  • 19. Successful combination treatment of a patient with progressive juvenile localized scleroderma (morphea) using imatinib, corticosteroids, and methotrexate.
    Inamo Y, Ochiai T.
    Pediatr Dermatol; 2013 Jun 15; 30(6):e191-3. PubMed ID: 23025697
    [Abstract] [Full Text] [Related]

  • 20. Linear scleroderma en coup de sabre and brain calcification: is there a pathogenic relationship?
    Kasapçopur O, Ozkan HC, Tüysüz B.
    J Rheumatol; 2003 Dec 15; 30(12):2724-5; author reply 2725. PubMed ID: 14719224
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.